Trials / Terminated
TerminatedNCT03869645
CAPERE Thrombectomy System Post-Market Clinical Follow Up Study
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 18 (actual)
- Sponsor
- Medtronic Endovascular · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A prospective, single-arm, non-blinded study, intending to collect and evaluate data in up to forty (40) human subjects with acute thrombosis, treated with the CAPERE™ Thrombectomy System.
Detailed description
A prospective, single-arm, non-blinded study, intending to collect and evaluate data in up to forty (40) human subjects with acute thrombosis, treated with the CAPERE™ Thrombectomy System. Subjects will be evaluated based on VEINES QoL survey pre- and post-treatment (30-days).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | CAPERE Thrombectomy System | Mechanical thrombectomy of acute thrombus in peripheral vasculature with the CAPERE Thrombectomy System |
Timeline
- Start date
- 2019-06-01
- Primary completion
- 2020-08-26
- Completion
- 2020-08-26
- First posted
- 2019-03-11
- Last updated
- 2022-09-13
Locations
3 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03869645. Inclusion in this directory is not an endorsement.